Luminoah Demonstrates Next-Generation Enteral Nutrition Platform at CES 2026
January 5, 2026 At CES® 2026, Luminoah will demonstrate Luminoah Flow™, its closed-loop, personalized enteral nutrition platform designed to improve outcomes and quality of life for individuals who rely on tube feeding. The system integrates intelligent software with connected hardware to simplify nutrition delivery, enhance safety, and enable more personalized care. “We are honored to […]
American Gastroenterological Association and MATTER Select Luminoah for New GI Care Innovation Program
Luminoah has been selected as one of eleven companies to participate in the inaugural AGA Incubator: Improving GI Care, co-led by the American Gastroenterological Association (AGA) and MATTER. Digestive diseases affect tens of millions of people in the United States, underscoring the need for innovative approaches that improve care, outcomes, and patient experience. The AGA […]
Luminoah Wins Prize at Pediatric Health Innovation Summit
Innovation for children requires intention, collaboration, and a deep understanding of what families experience. As a parent who has navigated pediatric healthcare firsthand, it was inspiring to see that commitment brought to life at the Pediatric Healthcare Innovation Summit. For two days, leaders from children’s hospitals, investors, clinicians, and entrepreneurs gathered at Georgia Institute of […]
The Story Behind Luminoah’s Name
When Noah rang the bell at UVA Children’s Hospital, marking the end of his treatment, there was a painting of a rocket ship on the wall. During the long days of chemo, we often talked about space — a topic that fascinated him. In March 2020, while thinking about a name for the company, those […]
Luminoah Wins MedTech Innovator Best Video Award and Early-Stage Grand Prize Funding
Charlottesville, VA – October 8, 2025 – Luminoah, a MedTech company developing the first and only closed-loop personalized nutrition platform, today announced it has won MedTech Innovator’s (MTI) 2025 Best Video Award and received $25,000 in non-dilutive funding as one of the top five finalists in the Early-Stage Grand Prize competition. This recognition marks the […]